Lakhmir S. Chawla's most recent trade in Revelation Biosciences Inc was a trade of 181 Common Stock done at an average price of $3.9 . Disclosure was reported to the exchange on Feb. 11, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Revelation Biosciences Inc | Lakhmir S. Chawla | Director | Grant, award, or other acquisition of securities at price $ 3.87 per share. | 11 Feb 2025 | 181 | 181 | - | 3.9 | 700 | Common Stock |